Shi Chen

No. 26, Yuancun 2nd Cross Road
Guangzhou, 510655, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 81 publications

A microbial chromatin remodeler drives gastric cancer progression and immune evasion by reprogramming the host epigenome.

A microbial chromatin remodeler drives gastric cancer progression and immune evasion by reprogramming the host epigenome.

Journal: Cell host & microbe

Published: January 20, 2026

Stripping cell-free DNA from its immune complex is essential for inflammation control using DNase I.

Stripping cell-free DNA from its immune complex is essential for inflammation control using DNase I.

Journal: Biomaterials

Published: August 13, 2025

Age-Stratified Clinicopathological Features and Efficacy of Adjuvant Chemotherapy in Resectable Gastric Cancer: An East-West Population-Based Study.

Age-Stratified Clinicopathological Features and Efficacy of Adjuvant Chemotherapy in Resectable Gastric Cancer: An East-West Population-Based Study.

Journal: Current oncology (Toronto, Ont.)

Published: July 02, 2025

Inhalable Artificial Polymeric Nucleases Degrading Neutrophil Extracellular Trap-DNAs and Alleviating Pulmonary Fibrosis.

Inhalable Artificial Polymeric Nucleases Degrading Neutrophil Extracellular Trap-DNAs and Alleviating Pulmonary Fibrosis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: March 24, 2025

CircZFAND6 suppresses gastric cancer metastasis and reduces resistance to TKI therapy.

CircZFAND6 suppresses gastric cancer metastasis and reduces resistance to TKI therapy.

Journal: Molecular cancer

Published: March 12, 2025

Feasibility, safety and preliminary effect of exercise prehabilitation in patients with esophageal cancer undergoing surgery: an open-label, randomized, parallel-group pilot and feasibility study.

Feasibility, safety and preliminary effect of exercise prehabilitation in patients with esophageal cancer undergoing surgery: an open-label, randomized, parallel-group pilot and feasibility study.

Journal: BMC sports science, medicine & rehabilitation

Published: February 27, 2025

Marine natural product Methyl mycophenolate inhibits gastric cancer growth through regulating p53 and the downstream pathways.

Marine natural product Methyl mycophenolate inhibits gastric cancer growth through regulating p53 and the downstream pathways.

Journal: Cancer cell international

Published: January 30, 2025

Immune checkpoint inhibitors improve the efficacy of neoadjuvant chemotherapy in advanced gastric cancer: a retrospective cohort study.

Immune checkpoint inhibitors improve the efficacy of neoadjuvant chemotherapy in advanced gastric cancer: a retrospective cohort study.

Journal: Therapeutic advances in medical oncology

Published: October 29, 2024

Novel surveillance protocol for gastric cancer based on CEA: a high-volume multi-center study.

Novel surveillance protocol for gastric cancer based on CEA: a high-volume multi-center study.

Journal: BMC cancer

Published: September 06, 2024

Risk factors of esophagojejunal anastomotic leakage after total gastrectomy for gastric and Siewert type II/III esophagogastric cancer: a retrospective analysis from a tertiary hospital.

Risk factors of esophagojejunal anastomotic leakage after total gastrectomy for gastric and Siewert type II/III esophagogastric cancer: a retrospective analysis from a tertiary hospital.

Journal: Frontiers in oncology

Published: August 15, 2024

Author Correction: Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial.

Author Correction: Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial.

Journal: Nature medicine

Published: January 08, 2024

Synthetic polypeptides inhibit nucleic acid-induced inflammation in autoimmune diseases by disrupting multivalent TLR9 binding to LL37-DNA bundles.

Synthetic polypeptides inhibit nucleic acid-induced inflammation in autoimmune diseases by disrupting multivalent TLR9 binding to LL37-DNA bundles.

Journal: Nature nanotechnology

Published: December 02, 2023

Showing 1-12 of 81

Last Updated: 09/26/2026